Why “stacks” and combination deals weaken a supervisor briefing
A student project supervisor briefing is an academic control document. It has to let a supervisor check the scientific rationale, the quantities required for an in-vitro assay, the storage route, the waste route and the paperwork attached to each material. When a purchase request arrives as a “stack”, a “starter bundle” or a combination deal, those checks become harder. A bundle name can hide the individual catalogue items, batch references and certificates. Itemisation is the control point.
Research Sciences describes its catalogue as research-use-only materials for controlled in-vitro laboratory work, and its published guidance says it does not supply blended peptides. Instead, the shop recommends buying peptides individually and combining them only within a controlled experimental design. That position suits a student project briefing because the supervisor can approve each compound on its own evidence, then approve the experimental design that brings them together. A request that says “Ipamorelin + CJC-1295 stack” collapses those two decisions into one. The supervisor cannot easily see which vial, batch CoA, storage condition or quantity belongs to which compound. Catalogue examples such as Ipamorelin 5mg and CJC-1295 (No DAC) 5mg are separate items, not a pre-blended product; the purchase request should mirror that structure.
Combination deals also invite scope creep. A bundle may appear to offer a ready-made experiment, but the supervisor still has to confirm that each material is suitable for the intended in-vitro application, that the laboratory can store it correctly, and that the purchaser can meet lawful use, safe handling, storage and disposal duties, including COSHH and local safety standards. The shop’s products are not for human or veterinary use; they are not medicines, medical devices, injectables, treatments or food supplements. A bundle label can blur that boundary. The briefing should keep it sharp: separate compounds, separate evidence, separate storage notes, and a clear statement that all materials are for research use only.
The shop describes batch-level verification, transparent CoAs and a CoA for every product, with purity and identity checked by HPLC and exact purity stated on the CoA. A combination deal can make it unclear which CoA applies to which vial, and cap colours are not indicators of identity or quality. A line-item request lets the supervisor check the batch CoA and label reference against the material the student intends to use. Convenience should never outrank traceability.
How to structure a research purchase request around individual catalogue items
A workable request uses one line per catalogue item, even when the experimental design uses several compounds together. Each line should give the product name as the catalogue states it, the pack size shown on the product page, the number of vials requested, the role of that material in the in-vitro work, and the documentation reference attached. For example, a request might list BPC-157 10mg on one line and TB-500 5mg on another, with separate notes for a storage container and any 10ml mixing water or bacteriostatic water required for laboratory preparation. The supervisor can then review each item against its product page and batch CoA rather than unpicking a bundle.
A simple template keeps the briefing readable: catalogue item and pack size; quantity of vials; in-vitro assay role; batch or label reference; CoA attached; storage before opening; storage after reconstitution, if relevant; and disposal route. Record the label reference as the shop describes it, for example a SKU code combined with an expiry date such as BPC10-03/27, because that reference links to the corresponding CoA. If the request includes a restocked item, note that a shared Internal Test Reference does not confirm that separate deliveries come from the same production lot or have had separate independent testing. That is the kind of detail a supervisor needs before signing off.
When the supervisor asks for a shortlist, review the current research catalogue through Buy peptides and attach the individual product page and batch CoA for each proposed item. This is not a prompt to order a bundle; it is a way to confirm current catalogue wording, pack sizes and documentation routes. The request should avoid phrases such as “stack”, “combo” or “deal” and use laboratory language instead: stock solution, diluent volume, assay concentration, batch record and storage condition. If the protocol genuinely combines compounds in vitro, the briefing can describe separate stock preparations and planned assay concentrations, while making clear that the shop’s reconstitution calculator and materials are for laboratory research only and are not for human or veterinary dosing or clinical use. The request should also state that the purchaser is responsible for lawful use, safe handling, storage and disposal, and that materials are not for human or veterinary use.
Documentation, storage and in-vitro handling notes for the briefing pack
The documentation pack should be built around the batch, not the bundle. Research Sciences describes a CoA for every product, with HPLC purity and identity information, and the homepage lists “CoAs Janoshik Analytical Reports”; the researcher should check the CoA that accompanies the specific batch. The shop’s current published wording describes peptides as typically supplied at ≥99% purity by HPLC, but exact purity is stated on the CoA, so the live site wording and batch document should be reconfirmed. Heavy-metal and endotoxin screening should likewise be checked on the actual batch document, not a marketing summary.
For lyophilised materials, the shop’s quick guide says to store at –20°C or below, sealed with desiccant, protected from moisture, heat and light, and to avoid repeated freeze–thaw cycles. Vials should reach room temperature before opening, and work should take place in a clean environment with only the amount required for the experiment removed. Reconstituted material is less stable and should be stored at 2–8°C for short-term laboratory use. These notes should appear against each line item, because the supervisor needs to confirm that the laboratory can meet them. The briefing should also record the COSHH assessment, the waste route and the named handler.
Reconstitution language must stay inside the in-vitro laboratory workflow. The briefing can record the diluent volume and target concentration for an assay, and note that the shop supplies preparation tools and a reconstitution calculator for laboratory research use only. It should state clearly that the calculator and materials are not for medical or clinical use and that the products are not for human or veterinary use. That sentence keeps a student project on the research side of the shop’s compliance model. The shop says orders inconsistent with its compliance standards may be refused, so a clean, itemised briefing is a practical way to reduce avoidable back-and-forth.
The briefing pack should answer four questions for every line: which batch CoA is attached, where the vial will be stored, who will handle it, and how waste will be disposed of under local rules. If the student cannot answer those questions for a proposed “stack”, the item is not ready for supervisor approval. The request should return to individual catalogue items, individual CoAs and a written in-vitro experimental design.
Grew up in Jaipur, studied robotics in Boston, now rooted in Nairobi running workshops on STEM for girls. Sarita’s portfolio ranges from Bollywood retrospectives to solar-powered irrigation tutorials. She’s happiest sketching henna patterns while binge-listening to astrophysics podcasts.